Tarsus Pharmaceuticals, Inc. ($TARS)
Filing Information
| Accession Number | 0001842190-26-000007 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 19, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
1,144
Total Value
$78,203.59
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Mar 17, 2026 | Sale | 375 | $69.42 | $26,032.50 | 24,077 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Mar 18, 2026 | Sale | 379 | $68.71 | $26,041.09 | 23,698 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Mar 19, 2026 | Sale | 390 | $67.00 | $26,130.00 | 23,308 | Direct | โ | View Details |